Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2020

Nov 27, 2020

32106_dirs_2020-11-27_b3dcc545-e31e-4123-bcca-45ad9835d493.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2020-11-24

Reporting Person: Casdin Partners Master Fund, L.P. (10% Owner)
Reporting Person: Casdin Capital, LLC (10% Owner)
Reporting Person: Casdin Partners GP, LLC (10% Owner)
Reporting Person: Casdin Eli (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-24 Common Stock, par value $.001 per share P 1600000 $22.50 Acquired 7440107 Direct

Footnotes

F1: The reported securities will be purchased by Casdin Partners Master Fund, L.P. (the "Master Fund") in a private transaction (the "Transaction"). As of November 24, 2020, all material conditions precedent to closing the Transaction have been satisfied.

F2: The securities are owned directly by the Master Fund and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to the Master Fund, (ii) Casdin Partners GP, LLC, the general partner of the Master Fund, and (ii) Eli Casdin, the managing member of Casdin Capital, LLC and Casdin Partners GP, LLC.